HR 1922 · 119th CongressIn Committeecongress.gov ↗

Ensuring Access to Essential Drugs Act

What this bill does

AI plain-language summary

This bill would remove certain brand-name drugs from a Medicare program that requires drug companies to give discounts to seniors. The program normally makes drug makers provide discounts to Medicare Part D patients who have spent more than their yearly deductible on prescription drugs. The bill would exempt oral brand-name drugs that are treated as generic drugs under a different government program called Medicaid.

Introduced

March 6, 2025

Policy Area

Health

Your Vote

Discussion (0)

Explain what is at stake in this bill.

Sign in to join the discussion.

No comments yet. Be the first.